Eric Zijlstra

Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial

Inge B. Halberg, Karsten Lyby, Karsten Wassermann et al. · The Lancet Diabetes & Endocrinology · 2019 · 166 citations

Subcutaneous Insulin Glargine, Diabetes Management, Insulin Management +6

Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single‐centre, randomized controlled trial

Tim Heise, Leszek Nosek, Sibylle Dellweg et al. · Diabetes Obesity and Metabolism · 2014 · 105 citations

Pharmacological properties of faster‐acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double‐blind, crossover trial

Tim Heise, Eric Zijlstra, Leszek Nosek et al. · Diabetes Obesity and Metabolism · 2016 · 76 citations · Full text

Impact of Injection Speed, Volume, and Site on Pain Sensation

Eric Zijlstra, Johannes Jahnke, Annelie Fischer et al. · Journal of Diabetes Science and Technology · 2017 · 72 citations · Full text

Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus

Tim Heise, Kirstine L. Stender-Petersen, Ulrike Hövelmann et al. · Clinical Pharmacokinetics · 2016 · 68 citations · Full text